Invitation to Cereno Scientific’s Capital Markets Day on October 17, 2024
Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for rare and common cardiovascular disease, today communicated the formal invitation to the Company’s Capital Markets Day on October 17, 2024.The Capital Markets Day will provide an opportunity for investors, analysts, and media to get insights on Cereno’s clinical and preclinical development portfolio and operations as well as its future growth strategy. The program will include presentations by the Cereno executive management team as well as key external speakers. A detailed agenda will